Description
Description
Lyme Disease ImmuneSelect is a peptide pool composed of 41 peptides that cover MHC-II restricted epitopes of Borrelia burgdorferi (Lyme Disease Borrelia). Peptide sequences are derived from:
- Borrelia P83/P100 antigen
- Histidine kinase
- Immunogenic protein P37
- Outer surface protein A
- Outer surface protein C
The purity of each peptide is ≥90% (HPLC-MS).
Application
The in-vitro stimulation of Peripheral Blood Mononuclear Cells (PBMCs) with Lyme Disease ImmuneSelect Peptide Pool activates memory T cells specific to the infection, leading to cytokine secretion and the increased expression of specific surface markers.
Reviews
There are no reviews yet.